CAPTRUST Financial Advisors
LVAC

CAPTRUST Financial Advisors’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,581
Closed -$108K – 2396
2022
Q4 		$108K Buy
+10,581
New +$107K ﹤0.01% 2044

Other funds holding LVAC

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

CAPTRUST Financial Advisors's LVAC Position: Q1 2023 in Review

CAPTRUST Financial Advisors sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2023, closing a stake of 10,581 shares — an estimated $108K sold.

CAPTRUST Financial Advisors first reported a position in LVAC in Q4 2022 and held it in 1 quarter. The position peaked at $108K in Q4 2022. 54 funds tracked by Wall St. Rank hold LVAC as of Q1 2023.

  • CAPTRUST Financial Advisors reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,581 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $108K.
  • CAPTRUST Financial Advisors first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $108K in Q4 2022.
  • 54 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.